Trials / Conditions / Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)
Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)
4 registered clinical trials studyying Ph+ Acute Lymphoblastic Leukemia (Ph+ALL) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo NCT07493408 | The University of Hong Kong | Phase 2 |
| Not Yet Recruiting | Olverembatinib as Maintenance Therapy or Preemptive Therapy After Allo-HSCT in Ph+ALL NCT06658925 | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 |
| Withdrawn | Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies NCT03414450 | EDDC (Experimental Drug Development Centre), A*STAR Research Entities | Phase 1 |